CIRAMZAPriority claimed from 21/12/2010; Application No. : 85202457 ;United States ofAmerica (Class 5)

The trademark application number 2156227 is currently marked as "UNKNOWN" in the official trademark registry.

The trademark application number 2156227 is owned by IM CLONE LLC.

Trademark application number 2156227 is filed under Class 5, which relates to the specified goods and services.

The trademark agent associated with application number 2156227 is LALL & SETHI.

Yes, trademark application number 2156227 was published in Journal No. 1741.

Trademark application number 2156227 relates to "PHARMACEUTICAL PREPARATIONS, NAMELY, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF ALCOHOL USE DISORDERS, ANXIETY, BONE AND SKELETAL DISEASES AND DISORDERS, BLOOD DISORDERS, CANCER, CARDIOVASCULAR DISEASES, CHOLESTEROL DISORDERS, CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS, DIABETES, ENDOCRINE DISEASES AND DISORDERS, GASTROINTESTINAL DISEASES AND DISORDERS, HORMONAL DISEASES AND DISORDERS, INFLAMMATION AND INFLAMMATORY DISEASES AND DISORDERS, LIVER DISEASES AND DISORDERS, KIDNEY DISEASES AND DISORDERS, NEURODEGENERATIVE DISEASES AND DISORDERS, NEUROLOGICAL DISORDERS, OBESITY, PAIN, REPRODUCTIVE SYSTEM DISEASES AND DISORDERS, UROLOGICAL DISORDERS, DYSLIPIDEMIA, SLEEP DISORDERS, MIGRAINES, METABOLIC DISEASES AND DISORDERS; ANTIPSYCHOTICS; ANTIDEPRESSANTS; ANXIET SPECTRUM DISORDERS; ATHEROSCLEROSIS; ALZHEIMER PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF DIABETES; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF RHEUMATOID ARTHRITIS; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF CROHNS DISEASE, SYSTEMIC LUPUS ERYTHEMATOSUS, AND ANKYLOSING SPONDYLITIS DISEASE; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF PSORIASIS AND PSORIATIC ARTHRITIS; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF AUTOIMMUNE DISORDERS".